NCT06449287

Brief Summary

This project will be a three-group controlled 6-wk feeding study where all meals are prepared and provided to obese participants. All participants will be fed a 25% energy-restricted diet. Two diets will be very low in carbohydrate (i.e., ketogenic diets) designed to induce nutritional ketosis and fat loss. Another diet will be low in fat and saturated fat but contain the same total calories. Participants will be randomly assigned to a Ketone Supplement group who are provided an exogenous pre-formed source of beta-hydroxybutyrate (BOHB) or a Control group that only receives the standard ketogenic diet. Randomization will be stratified based on insulin resistance, sex, and body composition to ensure balanced group assignment. Because of timing of recruitment (i.e., after most of the ketogenic groups have already completed the study), the low-fat group will not be randomized. Outcome measurements will be made at various intervals over the 6-wk intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 5, 2018

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2019

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 21, 2019

Completed
4.8 years until next milestone

First Submitted

Initial submission to the registry

May 31, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 10, 2024

Completed
Last Updated

December 19, 2024

Status Verified

December 1, 2024

Enrollment Period

8 months

First QC Date

May 31, 2024

Last Update Submit

December 16, 2024

Conditions

Keywords

ketonesmetabolismweight loss

Outcome Measures

Primary Outcomes (6)

  • Daily Ketone/Glucose Monitoring

    Daily fasting glucose/ketones will be assessed using capillary finger stick lancing. A small drop of blood will be obtained once daily, while fasting, using enzymatic strips fitted for a handheld analyzer (KetoMojo). All the data will be stored in the device's internal memory.

    Up to 6 weeks

  • Cholesterol (mg/dl)

    Fasting venous blood will be collected biweekly to measure cholesterol.

    up to six weeks

  • Insulin (mIU/L)

    Fasting venous blood will be collected biweekly.

    up to six weeks

  • Glucose (mg/dL)

    Fasting venous blood will be collected biweekly.

    up to six weeks

  • Lean Mass (kg)

    DEXA Scanning will be biweekly to assess lean mass

    up to six weeks

  • Fat Mass (kg)

    DEXA Scanning will be biweekly to assess fat mass

    up to six weeks

Secondary Outcomes (4)

  • Neuropsychological Outcome 1 - Reaction time (Throughput)

    up to six weeks

  • Neuropsychological Outcome 1 - Visual Short Term Memory (Throughput)

    up to six weeks

  • Neuropsychological Outcome 1 - Spatial Processing (Throughput)

    up to six weeks

  • Urine Chemistries

    up to 6 weeks

Study Arms (3)

Ketogenic Diet

EXPERIMENTAL

Participants will have all their meals prepared in the Instructional Kitchen in the Ohio Union, irrespective of group assignment. They will receive a daily caloric intake equal to 75% of their estimated requirement to maintain weight, which should result in weight loss over the 6-week period. For those in the ketogenic groups, daily macronutrient intake will consist of 35 g of carbohydrates and moderate protein calculated as 1.5 g/kg of reference weight. The remaining caloric intake will consist of fat. A wide range of whole foods will be incorporated into the meals, including non-starchy vegetables, meats, nuts and seeds, oils, cheese, butter, cream, and eggs. The menu will be shared with participants prior to enrolling in the study so they know what to expect in terms of the meal plans.

Other: DietBiological: Blood DrawBiological: Ketone/Glucose MonitoringOther: Body CompositionBiological: Urine AnalysisBehavioral: Neuropsychological Measures - ANAM

Ketogenic Diet + Ketone Salt

EXPERIMENTAL

Participants will have all their meals prepared in the Instructional Kitchen in the Ohio Union, irrespective of group assignment. They will receive a daily caloric intake equal to 75% of their estimated requirement to maintain weight, which should result in weight loss over the 6-week period. For those in the ketogenic groups, daily macronutrient intake will consist of 35 g of carbohydrates and moderate protein calculated as 1.5 g/kg of reference weight. The remaining caloric intake will consist of fat. A wide range of whole foods will be incorporated into the meals, including non-starchy vegetables, meats, nuts and seeds, oils, cheese, butter, cream, and eggs. The menu will be shared with participants prior to enrolling in the study so they know what to expect in terms of the meal plans. This group will also be provided a ketone salt supplement to take x2 daily.

Other: DietBiological: Blood DrawBiological: Ketone/Glucose MonitoringOther: Body CompositionBiological: Urine AnalysisBehavioral: Neuropsychological Measures - ANAM

Low Fat Diet +Placebo

ACTIVE COMPARATOR

The low-fat comparison group will also be provided all their food. Their diet will also be restricted in calories and have the same level of protein, but it will be lower in fat and higher in carbohydrate. The low-fat diet will consist of approximately 25% fat, with the remaining calories coming from carbohydrates (approximately 55% after accounting for protein at around 20%). Added sugars will be kept relatively low (less than 25 g/day) with a focus on unprocessed carbohydrate-rich foods. Saturated fat will be limited to less than 10% of total energy, with a focus on unsaturated fat sources.

Other: DietBiological: Blood DrawBiological: Ketone/Glucose MonitoringOther: Body CompositionBiological: Urine AnalysisBehavioral: Neuropsychological Measures - ANAM

Interventions

DietOTHER

The diet intervention will start after all baseline testing is complete

Ketogenic DietKetogenic Diet + Ketone SaltLow Fat Diet +Placebo
Blood DrawBIOLOGICAL

Blood samples will be collected biweekly.

Ketogenic DietKetogenic Diet + Ketone SaltLow Fat Diet +Placebo

Hand-held glucometer will be used daily to monitor dietary intervention adherence.

Ketogenic DietKetogenic Diet + Ketone SaltLow Fat Diet +Placebo

DEXA Scanning will be done pre-, mid-, and post- intervention.

Ketogenic DietKetogenic Diet + Ketone SaltLow Fat Diet +Placebo
Urine AnalysisBIOLOGICAL

24 hour urine collection will be done biweekly.

Ketogenic DietKetogenic Diet + Ketone SaltLow Fat Diet +Placebo

The first cognitive assessment will be done via Automated Neuropsychological Assessment Metrics (ANAM). This cognitive battery is a library of computer-based tests of domains including attention, concentration, reaction time, memory, processing speed, decision-making, and executive function.

Ketogenic DietKetogenic Diet + Ketone SaltLow Fat Diet +Placebo

Eligibility Criteria

Age21 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • BMI \>27 and =35 kg/m2

You may not qualify if:

  • have diabetes, liver, kidney, or other metabolic or endocrine dysfunction, or using diabetic medications.
  • Currently consuming a low-carbohydrate diet
  • Weight loss of \>10% in past 6 months -Currently pregnant or nursing, or planning to become pregnant during the study
  • Major psychiatric disorder (e.g., schizophrenia, bipolar disorder)
  • Excessive alcohol intake (acute or chronic) defined as average consumption of 3 or more alcohol-containing beverages daily or consumption of more than 14 alcoholic beverages per week

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Ohio State University

Columbus, Ohio, 43210, United States

Location

Related Publications (3)

  • Kackley ML, Brownlow ML, Buga A, Crabtree CD, Sapper TN, O'Connor A, Volek JS. The effects of a 6-week controlled, hypocaloric ketogenic diet, with and without exogenous ketone salts, on cognitive performance and mood states in overweight and obese adults. Front Neurosci. 2022 Sep 30;16:971144. doi: 10.3389/fnins.2022.971144. eCollection 2022.

  • Belany P, Kackley ML, Zhao S, Kluwe B, Buga A, Crabtree CD, Nedungadi D, Kline D, Brock G, Simonetti OP, Volek JS, Joseph JJ. Effects of Hypocaloric Low-Fat, Ketogenic, and Ketogenic and Ketone Supplement Diets on Aldosterone and Renin. J Clin Endocrinol Metab. 2023 Jun 16;108(7):1727-1739. doi: 10.1210/clinem/dgad009.

  • Buga A, Kackley ML, Crabtree CD, Bedell TN, Robinson BT, Stoner JT, Decker DD, Hyde PN, LaFountain RA, Brownlow ML, O'Connor A, Krishnan D, McElroy CA, Kraemer WJ, Volek JS. Fasting and diurnal blood ketonemia and glycemia responses to a six-week, energy-controlled ketogenic diet, supplemented with racemic R/S-BHB salts. Clin Nutr ESPEN. 2023 Apr;54:277-287. doi: 10.1016/j.clnesp.2023.01.030. Epub 2023 Feb 4.

MeSH Terms

Conditions

Weight LossKetosis

Interventions

DietBlood Specimen CollectionKetonesBody CompositionUrinalysis

Condition Hierarchy (Ancestors)

Body Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsAcidosisAcid-Base ImbalanceMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Nutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaSpecimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative TechniquesOrganic ChemicalsBiochemical PhenomenaChemical PhenomenaMetabolismBody ConstitutionClinical Chemistry TestsDiagnostic Techniques, Urological

Study Officials

  • Jeff Volek, PhD

    Ohio State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 31, 2024

First Posted

June 10, 2024

Study Start

July 5, 2018

Primary Completion

March 1, 2019

Study Completion

August 21, 2019

Last Updated

December 19, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations